Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Equity (2016 - 2025)

Guided Therapeutics' Return on Equity history spans 14 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Guided Therapeutics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for GTHP hit a ceiling of 0.02% in Q2 2023 and a floor of 0.0% in Q2 2021.
  • Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2024.
  • Biggest five-year swings in Return on Equity: rose 1bps in 2022 and later decreased -1bps in 2023.
  • Tracing GTHP's Return on Equity over 5 years: stood at 0.0% in 2021, then soared by 437bps to 0.02% in 2022, then crashed by -40bps to 0.01% in 2023, then crashed by -47bps to 0.0% in 2024, then grew by 11bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for GTHP at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.